A Day Up For Kinnate Biopharma Inc.

Tue, Mar 29, 2022 at 05:30 PM
A Day Up For Kinnate Biopharma Inc.

Kinnate Biopharma Inc. (KNTE:NASDAQ) soared at $13.06, a gain of 25.9%. The stock appeared on our News Catalysts scanner on Mon, Mar 28, 2022 at 05:32 PM in the 'INVESTOR UPDATE' category. From Tue, Mar 15, 2022, the stock recorded 55.56% Up Days and 60.00% Green Days

About Kinnate Biopharma Inc. (KNTE:NASDAQ)

Kinnate Biopharma Inc a biopharmaceutical company focused on the discovery and development of small molecule kinase inhibitors for difficult-to-treat, genomically defined cancers.

Share
Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
monthly
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.